248 related articles for article (PubMed ID: 15925815)
1. Genetic implications of bilateral breast cancer: a population based cohort study.
Hartman M; Czene K; Reilly M; Bergh J; Lagiou P; Trichopoulos D; Adami HO; Hall P
Lancet Oncol; 2005 Jun; 6(6):377-82. PubMed ID: 15925815
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prognosis of synchronous and metachronous bilateral breast cancer.
Hartman M; Czene K; Reilly M; Adolfsson J; Bergh J; Adami HO; Dickman PW; Hall P
J Clin Oncol; 2007 Sep; 25(27):4210-6. PubMed ID: 17878475
[TBL] [Abstract][Full Text] [Related]
3. Risk of bilateral renal cell cancer.
Wiklund F; Tretli S; Choueiri TK; Signoretti S; Fall K; Adami HO
J Clin Oncol; 2009 Aug; 27(23):3737-41. PubMed ID: 19597028
[TBL] [Abstract][Full Text] [Related]
4. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
5. Bilateral breast cancer.
Gogas J; Markopoulos C; Skandalakis P; Gogas H
Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195
[TBL] [Abstract][Full Text] [Related]
6. Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).
Molina-Montes E; Pollán M; Payer T; Molina E; Dávila-Arias C; Sánchez MJ
Gynecol Oncol; 2013 Aug; 130(2):340-5. PubMed ID: 23648471
[TBL] [Abstract][Full Text] [Related]
7. Women with multiple primary breast cancers diagnosed within a five year period, 1994-1998.
Howe HL; Weinstein R; Alvi R; Kohler B; Ellison JH
Breast Cancer Res Treat; 2005 Apr; 90(3):223-32. PubMed ID: 15830135
[TBL] [Abstract][Full Text] [Related]
8. [Bilateral breast cancer. Incidence and risk factors].
El Hanchi Z; Berrada R; Fadli A; Ferhati D; Brahmi R; Baydada A; Kharbach A; Chaoui A
Gynecol Obstet Fertil; 2004 Feb; 32(2):128-34. PubMed ID: 15123135
[TBL] [Abstract][Full Text] [Related]
9. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
10. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up.
Mulder SA; Kranse R; Damhuis RA; Ouwendijk RJ; Kuipers EJ; van Leerdam ME
Dis Colon Rectum; 2012 May; 55(5):522-31. PubMed ID: 22513430
[TBL] [Abstract][Full Text] [Related]
11. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
12. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.
Schaapveld M; Visser O; Louwman WJ; Willemse PH; de Vries EG; van der Graaf WT; Otter R; Coebergh JW; van Leeuwen FE
Breast Cancer Res Treat; 2008 Jul; 110(1):189-97. PubMed ID: 17687645
[TBL] [Abstract][Full Text] [Related]
13. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.
Lee KD; Chen SC; Chan CH; Lu CH; Chen CC; Lin JT; Chen MF; Huang SH; Yeh CM; Chen MC
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2647-55. PubMed ID: 18843006
[TBL] [Abstract][Full Text] [Related]
14. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
15. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
16. [Breast cancer in men: incidence and types of associated previous synchronous and metachronous cancers].
Cutuli BF; Lacroze M; Dilhuydy JM; Florentz P; Velten M; Allavena C; De Lafontan B; Resbeut M; Campana F; Graic Y
Bull Cancer; 1992; 79(7):689-96. PubMed ID: 1467595
[TBL] [Abstract][Full Text] [Related]
17. The descriptive epidemiology of second primary breast cancer.
Bernstein JL; Lapinski RH; Thakore SS; Doucette JT; Thompson WD
Epidemiology; 2003 Sep; 14(5):552-8. PubMed ID: 14501270
[TBL] [Abstract][Full Text] [Related]
18. Incidence of metachronous contralateral breast cancer in the Canton of Zurich: a population-based study of the cancer registry.
Prater J; Valeri F; Korol D; Rohrmann S; Dehler S
J Cancer Res Clin Oncol; 2016 Feb; 142(2):365-71. PubMed ID: 26298838
[TBL] [Abstract][Full Text] [Related]
19. Survival after bilateral breast cancer: results from a population-based study.
Verkooijen HM; Chatelain V; Fioretta G; Vlastos G; Rapiti E; Sappino AP; Bouchardy C; Chappuis PO
Breast Cancer Res Treat; 2007 Nov; 105(3):347-57. PubMed ID: 17186359
[TBL] [Abstract][Full Text] [Related]
20. Bilateral breast carcinoma: clinical characteristics and its impact on survival.
Vuoto HD; García AM; Candás GB; Zimmermann AG; Uriburu JL; Isetta JA; Cogorno L; Khoury M; Bernabó OL
Breast J; 2010; 16(6):625-32. PubMed ID: 21070440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
